100 related articles for article (PubMed ID: 26655610)
1. Mighty MyD88 in Health and Disease.
Pulido JS; Raja H; Vile RG; Salomao DR; Viswanatha DS
Retina; 2016 Mar; 36(3):429-31. PubMed ID: 26655610
[No Abstract] [Full Text] [Related]
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
3. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
[No Abstract] [Full Text] [Related]
4. Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
Tan WJ; Wang MM; Ricciardi-Castagnoli P; Tang T; Chee SP; Lim TS; Chan ASY
Blood; 2019 Aug; 134(8):709-712. PubMed ID: 31292111
[No Abstract] [Full Text] [Related]
5. Clinical spectrum of vitreoretinal lymphoma and its association with MyD88 L265P mutation.
Carreno E; Clench T; Steeples LR; Salvatore S; Lee RWJ; Dick AD; Pawade J
Acta Ophthalmol; 2019 Feb; 97(1):e138-e139. PubMed ID: 30113125
[No Abstract] [Full Text] [Related]
6. MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.
Miserocchi E; Ferreri AJM; Giuffrè C; Cangi MG; Francaviglia I; Calimeri T; Ponzoni M; Pecciarini L; Bandello FM; Modorati GM
Retina; 2019 Apr; 39(4):679-684. PubMed ID: 30204732
[TBL] [Abstract][Full Text] [Related]
7. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
Raja H; Salomão DR; Viswanatha DS; Pulido JS
Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
[TBL] [Abstract][Full Text] [Related]
8. MyD-88 L265P mutations are present in some cases of vitreoretinal lymphoma.
Pulido JS; Salomao DR; Frederick LA; Viswanatha DS
Retina; 2015 Apr; 35(4):624-7. PubMed ID: 25768255
[TBL] [Abstract][Full Text] [Related]
9. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
Takhar JS; Doan TA; Gonzales JA
Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of immunoglobulin gene in metastatic Waldenström macroglobulinemia to the vitreous.
Shen DF; Fardeau C; Roberge FG; LeHoang P; Chan CC
Am J Ophthalmol; 2000 Mar; 129(3):395-6. PubMed ID: 10704566
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
[No Abstract] [Full Text] [Related]
12. Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid.
Albitar A; Ma W; DeDios I; Estella J; Agersborg S; Albitar M
Int J Lab Hematol; 2016 Apr; 38(2):133-40. PubMed ID: 26797804
[TBL] [Abstract][Full Text] [Related]
13. A novel MYD88 mutation, L265RPP, in Waldenström macroglobulinemia activates the NF-κB pathway to upregulate Bcl-xL expression and enhances cell survival.
Nagao T; Oshikawa G; Ishida S; Akiyama H; Umezawa Y; Nogami A; Kurosu T; Miura O
Blood Cancer J; 2015 May; 5(5):e314. PubMed ID: 25978434
[No Abstract] [Full Text] [Related]
14. [Waldenström macroglobulinaemia].
Tomowiak C; Poulain S; Debiais C; Guidez S; Leleu X
Presse Med; 2019; 48(7-8 Pt 1):832-841. PubMed ID: 31444019
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
Rajagopal R; Harbour JW
Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
[TBL] [Abstract][Full Text] [Related]
16. Improved accuracy of discrimination between IgM multiple myeloma and Waldenström macroglobulinaemia by testing for MYD88 L265P mutations.
Willenbacher W; Willenbacher E; Brunner A; Manzl C
Br J Haematol; 2013 Jun; 161(6):902-4. PubMed ID: 23560587
[No Abstract] [Full Text] [Related]
17. Intraocular lymphoma: more questions than answers.
Wakefield D; Zierhut M
Ocul Immunol Inflamm; 2009; 17(1):6-10. PubMed ID: 19294566
[No Abstract] [Full Text] [Related]
18. Detection of the MYD88 mutation by the combination of the allele-specific PCR and quenching probe methods.
Nogami S; Kawaguchi-Ihara N; Shiratori E; Ohtaka M; Itoh M; Tohda S
Int J Lab Hematol; 2017 Apr; 39(2):163-168. PubMed ID: 28042684
[TBL] [Abstract][Full Text] [Related]
19. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
20. MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
Shi M; Spurgeon S; Press R; Olson S; Fan G
Ann Hematol; 2015 Nov; 94(11):1941-4. PubMed ID: 26231802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
